These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 10498873)

  • 41. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
    Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
    Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
    Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
    Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered expression of the ZBRK1 gene in human breast carcinomas.
    Garcia V; Domínguez G; García JM; Silva J; Peña C; Silva JM; Carcereny E; Menendez J; España P; Bonilla F
    J Pathol; 2004 Feb; 202(2):224-32. PubMed ID: 14743505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
    Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.
    Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
    van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
    Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
    van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
    Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
    Liscia DS; Morizio R; Venesio T; Palenzona C; Donadio M; Callahan R
    Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for a transcriptional signature of breast cancer.
    Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
    Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
    Butcher DT; Rodenhiser DI
    Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
    Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
    Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
    Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
    Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle control of BRCA2.
    Vaughn JP; Cirisano FD; Huper G; Berchuck A; Futreal PA; Marks JR; Iglehart JD
    Cancer Res; 1996 Oct; 56(20):4590-4. PubMed ID: 8840967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.